Compare LH & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LH | ARES |
|---|---|---|
| Founded | 1971 | 1997 |
| Country | United States | United States |
| Employees | 70000 | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 29.1B |
| IPO Year | 2005 | 2014 |
| Metric | LH | ARES |
|---|---|---|
| Price | $368.33 | $134.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $382.25 | $146.55 |
| AVG Volume (30 Days) | 736.8K | ★ 2.0M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | 0.79% | ★ 4.04% |
| EPS Growth | ★ 18.33 | N/A |
| EPS | ★ 10.22 | N/A |
| Revenue | ★ $13,951,700,000.00 | $4,755,618,000.00 |
| Revenue This Year | $6.20 | $1.68 |
| Revenue Next Year | $5.39 | $18.34 |
| P/E Ratio | ★ $35.99 | $78.35 |
| Revenue Growth | 7.25 | ★ 28.86 |
| 52 Week Low | $245.00 | $95.80 |
| 52 Week High | $371.00 | $181.19 |
| Indicator | LH | ARES |
|---|---|---|
| Relative Strength Index (RSI) | 70.04 | 63.66 |
| Support Level | $256.51 | $117.74 |
| Resistance Level | $371.00 | $143.60 |
| Average True Range (ATR) | 11.47 | 4.68 |
| MACD | 3.03 | 1.94 |
| Stochastic Oscillator | 88.92 | 79.78 |
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Ares Management is one of the world's largest alternative-asset managers, with $671.3 billion in total assets under management, including $409.9 billion in fee-earning AUM, at the end of June 2026. The company has four main business segments: credit strategies ($440.5 billion in total AUM and $266.1 billion in fee-earning AUM), private equity ($24.5 billion/$13.9 billion), real estate/real assets ($151.2 billion/$88.6 billion), and other alternatives ($55.1 billion/$41.3 billion). The firm primarily serves institutional investors (80% of AUM) and high-net-worth individuals (20%). Ares operates through more than 35 offices in over 15 countries.